BRÈVE

sur Temedica GmbH

Temedica and Roche Expand Partnership with Digital Health Innovations

Temedica and Roche are expanding their successful collaboration, focusing on digital patient companion apps. Since the collaboration's inception, these apps have supported a significant number of patients. This partnership is set to enhance patient care through technological innovation.

The apps, Retinora and Brisa, focus on specific medical conditions. Retinora targets conditions like macular degeneration, while Brisa serves individuals with multiple sclerosis. The success of Brisa has led to its fifth-anniversary celebration and further expansion, including the growth of the “OcreKompass” service.

The apps leverage Temedica’s platform technology, providing personalized support and incorporating insights from real-world data. They offer users the chance to contribute to scientific research, maintaining user privacy in compliance with GDPR regulations.

R. E.

Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de Temedica GmbH